Open access
Open access
Powered by Google Translator Translator

Cardiology

ESC Scientific Statement | Sex differences in arterial hypertension.

26 Sep, 2022 | 12:10h | UTC

Sex differences in arterial hypertension: A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy – European Heart Journal

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ license

 


M-A | Association of gestational diabetes mellitus with cardiovascular and cerebrovascular diseases.

26 Sep, 2022 | 12:01h | UTC

Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis – The BMJ

News Release: Diabetes in pregnancy linked to risk of cardiovascular and cerebrovascular disease – BMJ Newsroom

 

Commentary on Twitter

 


Cohort Study | Association of high‐sensitivity Troponin T and I with mortality and cardiovascular outcomes in stable patients.

26 Sep, 2022 | 11:59h | UTC

Association of High‐Sensitivity Troponin T and I Blood Concentrations With All‐Cause Mortality and Cardiovascular Outcome in Stable Patients—Results From the INTERCATH Cohort – Journal of the American Heart Association

Invited Commentary: Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed? – Journal of the American Heart Association

 


Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy.

26 Sep, 2022 | 11:57h | UTC

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy – Journal of the American College of Cardiology

Editorial: Genetic Testing for Dilated Cardiomyopathy: Old School Is New School – Journal of the American College of Cardiology

News Release: Scientists develop a tool to determine if dilated cardiomyopathy has a genetic origin  – Centro Nacional de Investigaciones Cardiovasculares Carlos III

 

Commentary on Twitter

 


RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.

22 Sep, 2022 | 13:20h | UTC

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)

Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine

News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health

 


Secondary analysis of a RCT | Complete revascularization vs. culprit lesion–only PCI for angina-related quality of life in patients with STEMI.

22 Sep, 2022 | 13:17h | UTC

Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Original Study: #ESCCongress – Randomized Trial: Complete Revascularization Superior to Culprit-lesion-only PCI in Patients with ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Coronary Artery Disease

Related meta-analysis:

Meta-analysis: multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease

Meta-Analysis: Complete vs. Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction

Study: Nonculprit-lesion PCI Timing in Patients With ST-Segment Elevation Myocardial Infarction

Studies in patients with cardiogenic shock:

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine

One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine

 


A quality improvement study showed that a clinic–based aspirin deimplementation intervention can reduce inappropriate aspirin prescribing and bleeding in patients receiving warfarin for anticoagulation.

22 Sep, 2022 | 13:14h | UTC

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation – JAMA Network Open

News Release: Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds – Michigan Medicine

 

Commentary on Twitter

 


Consensus Statement | Cardiac computed tomographic imaging in cardio-oncology.

22 Sep, 2022 | 13:07h | UTC

Cardiac Computed Tomographic Imaging in Cardio-Oncology: An Expert Consensus Statement from the Society of Cardiovascular Computed Tomography, Endorsed by the International Cardio-Oncology Society (ICOS) – Journal of Cardiovascular Computed Tomography

 

Commentary on Twitter

 


M-A | Optimal pharmacologic treatment of heart failure with preserved and mildly reduced ejection fraction.

22 Sep, 2022 | 13:05h | UTC

Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis – JAMA Network Open

Related M-A: SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials – The Lancet (link to abstract – $ for full-text)

 


RCT | Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography.

22 Sep, 2022 | 13:04h | UTC

Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary: Intervention Cuts Risk for AKI After Coronary Angiography – HealthDay

 

Commentary on Twitter

 


RCT | Routine ultrasonography guidance for femoral vascular access for cardiac procedures improved first-pass success but did not reduce complications.

22 Sep, 2022 | 13:01h | UTC

Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial – JAMA Cardiology (free for a limited period)

Commentary: Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute? – JAMA Cardiology

 


Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.

22 Sep, 2022 | 13:00h | UTC

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists – European Heart Journal

 

Commentary on Twitter

 


Echocardiography in prone positioned critically ill patients: a wealth of information from a single view.

22 Sep, 2022 | 12:58h | UTC

Echocardiography in Prone Positioned Critically Ill Patients: A Wealth of Information from a Single View – Diagnostics

 


Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.

21 Sep, 2022 | 13:21h | UTC

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized Trial – JACC: Cardiovascular Interventions

Commentaries:

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension – PADN-CFDA – American College of Cardiology

 

Commentary on Twitter

 


ISHLT consensus statement | Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.

21 Sep, 2022 | 13:15h | UTC

ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery – the Journal of Heart and Lung Transplantation

Related Guideline: Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement – British Journal of Anaesthesia

 


Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.

20 Sep, 2022 | 13:34h | UTC

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial – Circulation

Commentary: 10-Year Data From BEST Trial Find No Significant Safety or MACE Differences Between PCI With EES Versus CABG – Cardiac Interventions Today

Original Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine

 


Long-term follow-up of a RCT | Outcomes after catheter-based renal artery denervation for resistant hypertension.

20 Sep, 2022 | 13:33h | UTC

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial – The Lancet (free registration required)

Commentary: SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss – TCTMD

Original Study: A Controlled Trial of Renal Denervation for Resistant Hypertension – New England Journal of Medicine

 


Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.

20 Sep, 2022 | 13:30h | UTC

Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials – Frontiers in Cardiovascular Medicine

 


A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction.

20 Sep, 2022 | 13:16h | UTC

A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction – JAMA Cardiology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Evaluation of an ambulatory ECG analysis platform using deep neural networks in routine clinical practice.

20 Sep, 2022 | 13:14h | UTC

Evaluation of an Ambulatory ECG Analysis Platform Using Deep Neural Networks in Routine Clinical Practice – Journal of the American Heart Association

 

Commentary on Twitter

 


RCT | Cerebral embolic protection during transcatheter aortic-valve replacement did not significantly reduce the incidence of periprocedural stroke.

19 Sep, 2022 | 12:49h | UTC

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope – TCTMD

Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement – PROTECTED TAVR – American College of Cardiology

Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven — Large trial comes up short in proving a definitive benefit to debris filters – MedPage Today (free registration required)

News Release: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement – Cedars-Sinai

 

Commentary on Twitter

 


Guideline Synopsis | AHA/ACC Guideline for the management of heart failure.

16 Sep, 2022 | 13:01h | UTC

Management of Heart Failure – JAMA (free for a limited period)

Original Article: #ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

 


AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.

16 Sep, 2022 | 13:00h | UTC

Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association – Circulation

 


Study | The specificity and positive predictive value of high-sensitivity cardiac troponin I for the diagnosis of myocardial infarction are reduced in older individuals.

16 Sep, 2022 | 12:57h | UTC

Influence of Age on the Diagnosis of Myocardial Infarction – Circulation

 


Consensus Statement | How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases.

16 Sep, 2022 | 12:56h | UTC

How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology (EAPC) – European Journal of Preventive Cardiology

 


Stay Updated in Your Specialty

No spam, just news.